Tardigrade
Tardigrade - CET NEET JEE Exam App
Exams
Login
Signup
Tardigrade
Question
Biology
In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:
Question Error Report
Question is incomplete/wrong
Question not belongs to this Chapter
Answer is wrong
Solution is wrong
Answer & Solution is not matching
Spelling mistake
Image missing
Website not working properly
Other (not listed above)
Error description
Thank you for reporting, we will resolve it shortly
Back to Question
Thank you for reporting, we will resolve it shortly
Q. In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:
NEET
NEET 2022
Biotechnology and its Applications
A
Genetically engineered lymphocytes are not immortal cells.
57%
B
Retroviral vector is introduced into these lymphocytes.
4%
C
Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stages
13%
D
Lymphocytes from patient's blood are grown in culture, outside the body.
26%
Solution:
Correct answer is (a) Genetically engineered lymphocytes are not immortal cells.